Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5736565 | 0.93 | BACE1 (0.64) | BACE1CTSD | |
| SCHEMBL8282794 | 0.93 | BACE1 (0.64) | BACE1CTSD | |
| SCHEMBL5666464 | 0.91 | BACE1 (0.75) | BACE1CTSD | |
| SCHEMBL8281555 | 0.91 | BACE1 (0.75) | BACE1CTSD | |
| SCHEMBL2877502 | 0.90 | BACE1 (0.73) | BACE1CTSD | |
| SCHEMBL8281586 | 0.90 | BACE1 (0.73) | BACE1CTSD | |
| Methylamine SCHEMBL5736229 | 0.89 | BACE1 (0.72) | BACE1CTSD | |
| Hydrochloric Acid SCHEMBL2875561 | 0.89 | BACE1 (0.72) | BACE1CTSD | |
| SCHEMBL8282633 | 0.88 | BACE1 (0.77) | BACE1CTSD | |
| SCHEMBL5737079 | 0.88 | BACE1 (0.74) | BACE1CTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005087215-A1 | SUBSTITUTED UREA AND CARBAMATE, PHENACYL-2-HYDROXY-3-DIAMINOALKANE, AND BENZAMIDE-2-HYDROXY-3-DIAMINOALKANE ASPARTYL-PROTEASE INHIBITORS | ELAN PHARMACEUTICALS, INC. (US) | 2005-09-22 | — | — | WO | disclosed |
| WO-2005070407-A1 | METHODS OF TREATMENT OF AMYLOIDOSIS USING ASPARTYL-PROTEASE INIHIBITORS | ELAN PHARMACEUTICALS, INC. (US) | 2005-08-04 | — | — | WO | disclosed |